Two thematic questions are at the forefront of gastrointestinal (GI) cancer research: What role will immunotherapy play in the management of these cancers, and how will further subtyping of tumors ...

Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations. Tumor-only sequencing has been adopted by many laboratories to guide precision oncology ...

Every tumor is unique. This makes it difficult to find the most effective therapy for treatment. The Tumor Profiler Center of the University Hospital Zurich, the University of Zurich, ETH Zurich and ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a new breast cancer signature included in the Caris ...

Illumina TruSight™ Oncology 500 v2 research assay is now available with built-in HRD biomarker detection, faster turnaround time, and lower tissue sample input Illumina's growing research and clinical ...

Every tumor is unique. This makes it difficult to find the most effective therapy for treatment. The Tumor Profiler Center of the University Hospital Zurich, the University of Zurich, ETH Zurich and ...

Indian Hedgehog expression and association with cetuximab benefit in metastatic colorectal cancer (mCRC): Evidence from CALGB (Alliance)/SWOG 80405. This is an ASCO Meeting Abstract from the 2026 ASCO ...

Next-generation sequencing (NGS) has transformed solid tumor molecular diagnostics by enabling comprehensive genomic profiling. However, traditional NGS workflows are often labor-intensive and ...

Despite the early promise of easily staining and analyzing hundreds of tumors, several problems remain with respect to the use of TMAs, such as bottlenecks in relation to the grading/evaluation stage ...

MADISON, Wis., Nov. 6, 2025 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tumor profiling platform for immunotherapy response ...